CW
Program

Longitude Prize on ALS

Funds AI-driven ALS drug-discovery teams through four stages worth up to £7.5 million total.

Challenge WorksUnited KingdomPrize

Teams progress through four stages over more than five years: Discovery (20 teams receive £100,000 to identify therapeutic targets), Prioritise (10 of those teams receive a further £200,000 to build the evidence base), Validate (5 teams receive £500,000 for wet-lab validation), and a final Winner stage where one team receives £1,000,000. An expert panel assesses and judges teams between each stage

AIBiotechMedtechNeurotech

Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.